Phillips 66 (R66)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 255.30 |
|---|---|
| 52-week range | 92.01 – 267.40 |
| Return, 1 month / 3 months | +14.1% / +37.3% |
| Return, 1 year / 3 years | +186.0% / +161.9% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 45.0% |
| Worst drawdown (1 year) | -19.8% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Phillips 66 is an energy company based in the United States that refines crude oil into fuels such as gasoline, diesel and jet fuel, and markets those fuels through service stations and wholesale channels. It also gathers, processes and transports natural gas liquids and other products through pipelines and terminals, produces petrochemicals through a chemicals joint venture, and supplies lubricants and other specialty products to industrial and consumer customers.
On this site Phillips 66 appears as a stock on the XETRA Stock Exchange (Germany), code R66, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Phillips 66 (R66) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 255.30 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 77 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 186.0% and over the last three months it rose 37.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 52.5% | ||
| From 52-week high | -3.1% | ||
| Momentum | 98 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 37.3% | ||
| 6-month return | 96.3% | ||
| 12-month return, skipping the last month | 150.7% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 45.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.8% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 8.3% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | +14.1% |
| 3 months | +37.3% |
| 6 months | +96.3% |
| 1 year | +186.0% |
| 3 years | +161.9% |
| 5 years | +326.1% |
Signals
| 50-day / 200-day average | 230.35 / 167.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | USD 1.1297 |
| 18 May 2026 | USD 1.1297 |
| 23 Feb 2026 | USD 1.1297 |
| 17 Nov 2025 | USD 1.0674 |
| 19 May 2025 | USD 1.0674 |
| 24 Feb 2025 | USD 1.0229 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.